$132.08
1.02% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
IE0005711209
Symbol
ICLR
Sector
Industry

ICON Plc Stock price

$132.08
-5.15 3.75% 1M
-71.59 35.15% 6M
-77.63 37.02% YTD
-186.64 58.56% 1Y
-84.02 38.88% 3Y
-32.31 19.65% 5Y
+64.75 96.17% 10Y
Nasdaq, Closing price Tue, May 20 2025
+1.33 1.02%
ISIN
IE0005711209
Symbol
ICLR
Sector
Industry

Key metrics

Market capitalization $10.67b
Enterprise Value $13.70b
P/E (TTM) P/E ratio 14.37
EV/FCF (TTM) EV/FCF 13.14
EV/Sales (TTM) EV/Sales 1.67
P/S ratio (TTM) P/S ratio 1.30
P/B ratio (TTM) P/B ratio 1.10
Revenue growth (TTM) Revenue growth -0.48%
Revenue (TTM) Revenue $8.19b
EBIT (operating result TTM) EBIT $1.19b
Free Cash Flow (TTM) Free Cash Flow $1.04b
Cash position $526.70m
EPS (TTM) EPS $9.19
P/E forward 12.36
P/S forward 1.34
EV/Sales forward 1.72
Short interest 1.54%
Show more

Is ICON Plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

ICON Plc Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a ICON Plc forecast:

12x Buy
63%
6x Hold
32%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a ICON Plc forecast:

Buy
63%
Hold
32%
Sell
5%

Financial data from ICON Plc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
8,193 8,193
0% 0%
100%
- Direct Costs 6,252 6,252
2% 2%
76%
1,941 1,941
5% 5%
24%
- Selling and Administrative Expenses 217 217
90% 90%
3%
- Research and Development Expense - -
-
-
1,724 1,724
0% 0%
21%
- Depreciation and Amortization 533 533
16% 16%
7%
EBIT (Operating Income) EBIT 1,191 1,191
8% 8%
15%
Net Profit 758 758
11% 11%
9%

In millions USD.

Don't miss a Thing! We will send you all news about ICON Plc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ICON Plc Stock News

Neutral
Business Wire
one day ago
DUBLIN--(BUSINESS WIRE)--ICON releases its ICON Cares 2024 Report.
Neutral
Business Wire
14 days ago
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe focusing on multi-indication cardiometabolic R&D for therapies targeting obesity and its comorbidities. Multi-indication studies are clinical trials that ...
Neutral
Seeking Alpha
19 days ago
ICON Public Limited Company (NASDAQ:ICLR ) Q1 2025 Earnings Call Transcript May 1, 2025 8:00 AM ET Company Participants Kate Haven - Vice President, Investor Relations Steve Cutler - Chief Executive Officer Nigel Clerkin - Chief Financial Officer Barry Balfe - Chief Operating Officer Conference Call Participants Ahmed Muhammad - Leerink Partners Patrick Donnelly - Citi David Windley - Jefferies...
More ICON Plc News

Company Profile

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

Head office Ireland
CEO Stephen Cutler
Employees 41,900
Founded 1989
Website www.iconplc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today